These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6114930)

  • 21. [Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications].
    Wachowiak R; Tezyk A
    Arch Med Sadowej Kryminol; 2003; 53(4):289-99. PubMed ID: 14971294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test].
    Chaignon M; Lucsko M; Aubert P; Guédon J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):963-9. PubMed ID: 6128964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
    Moppert J; Degen PH; Racine-Poon A
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced plasma binding of propranolol and oxprenolol and induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the dog.
    Belpaire FM; Rosseel MT; De Rick A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):303-4. PubMed ID: 7181586
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.
    Belpaire FM; Bogaert MG; Rosseneu M
    Eur J Clin Pharmacol; 1982; 22(3):253-6. PubMed ID: 6125395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
    Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
    J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of substrate depletion assay for early prediction of nonlinear pharmacokinetics in drug discovery: assessment of nonlinearity of metoprolol, timolol, and propranolol.
    Komura H; Kawase A; Iwaki M
    J Pharm Sci; 2005 Dec; 94(12):2656-66. PubMed ID: 16258981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.
    Piafsky KM; Borgá O; Odar-Cederlöf I; Johansson C; Sjöqvist F
    N Engl J Med; 1978 Dec; 299(26):1435-9. PubMed ID: 82206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Propranolol binding with plasma proteins and erythrocytes].
    Gneushev ET; Mamedov TSh; Gneusheva IA; Sivkov II
    Farmakol Toksikol; 1991; 54(1):55-7. PubMed ID: 1860502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inflammatory disease on plasma oxprenolol concentrations.
    Kendall MJ; Quarterman CP; Bishop H; Schneider RE
    Br Med J; 1979 Aug; 2(6188):465-8. PubMed ID: 158402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent asthma after treatment with beta-blocking agents.
    Anderson EG; Calcraft B; Jariwalla AG; Al-Zaibak M
    Br J Dis Chest; 1979 Oct; 73(4):407-8. PubMed ID: 45308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of beta-adrenoceptor blocking drugs into cerebrospinal fluid in rats.
    Ylitalo P; Lindén IB; Penttilä A; Vapaatalo H
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):84-7. PubMed ID: 2869640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
    van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
    J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymorphic metabolism of beta-adrenoceptor antagonists.
    Silas JH; Lennard MS; Tucker GT; Ramsay LE; Woods HF
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):11S-19S. PubMed ID: 6146335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of plasma and saliva levels of metoprolol and oxprenolol.
    Dawes CP; Kendall MJ; John VA
    Br J Clin Pharmacol; 1978 Mar; 5(3):217-21. PubMed ID: 656265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
    Decourt S; Roux A; Baglin A; Domart M; Aubert P; Flouvat B; Fritel D
    Acquis Med Recent; 1977; ():181-94. PubMed ID: 20725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.